Cell therapy for medication-related osteonecrosis of the jaw: update on treatment strategies
Despite extensive research since the first report of medication-related osteonecrosis of the jaw (MRONJ) in 2003, the optimal treatment and preventive modalities for the condition are not clear. Therefore, its management has been a concern in dentistry, oral and maxillofacial surgery, as well as dep...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Forum Multimedia Publishing LLC
2021-01-01
|
| Series: | European Cells & Materials |
| Subjects: | |
| Online Access: | https://www.ecmjournal.org/papers/vol041/pdf/v041a03.pdf |